drugset / Trial / NCT01307046

MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)

NCT01307046

Phase 3 Completed 336 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to evaluate the efficacy of MK-0954A in essential hypertension participants who are not adequately controlled with losartan.

Timeline

Start
2011-03-29
Primary completion
2012-02-07
Completion
2012-02-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 12.5 mg Oral
Subject Losartan Other / unclassified 100 mg Oral